Gold prices slip as Moderna vaccine progress weighs on haven metals

Xavier Galiana/Agence France-Presse/Getty Images The report comes a week after Pfizer PFE, +2.85% and BioNTech BNTX, +4.30% announced an experimental vaccine against COVID-19 that was at least 90% effective in Phase 3 studies, with the hopes of further progress on therapies and cures for the deadly disease overshadowing a resurgence of the spread of the infection across the globe and momentarily undercutting the appeal for precious metals overall.

December gold GCZ20, -0.01% declined $11.40, or 0.6%, to reach $1,874.80 an ounce, after the yellow metal saw a 3.4% weekly decline, based on the most-active contract, which was the largest since the week ended Sept. 25, FactSet data show.

Silver futures for December delivery SIZ20, -0.68% , meanwhile, shed 37 cents, or 1.5%, to reach around $24.41 an ounce, following its 3.5% weekly loss put in on Friday.

“Safe-haven gold fell as investors again reduced their exposure to the metal, in much a […]

Click here to view original web page at www.marketwatch.com

About the author: StockMan

Please remember:

The information provided here is for general knowledge and educational purposes only.
It is not intended to be a substitute for professional financial advice.
Every individual's financial situation is unique, and what works for one person may not work for another.
Before making any investment or financial decisions, you should always consult with a qualified financial advisor who understands your specific circumstances and goals.

Any information posted on the website has been prepared without taking into account your objectives, financial situation or needs and as such, should never be acted upon. Please be aware that any information posted on this site should not be considered to be financial advice and i am not a financial advisor.